See related Galvus Met[高糖優美] information |
|
製造商 |
Novartis |
代理/經銷商 |
Novartis |
成份 |
Per 50/500 mg tab Vildagliptin 50 mg, metformin HCl 500 mg. Per 50/850 mg tab Vildagliptin 50 mg, metformin HCl 850 mg. Per 50/1000 mg tab Vildagliptin 50 mg, metformin HCl 1,000 mg |
適應症 |
Treatment of patients with type 2 DM not adequately controlled on metformin alone, or vildagliptin alone, or who are already treated with the combination of vildagliptin & metformin |
用量 |
Adult Initially either 50 mg/850 mg or 50 mg/1000 mg bid. Daily recommended dose: 100 mg vildagliptin & 2 g metformin HCl. |
用法 |
Should be taken with food (Take w/ or immediately after meals to reduce GI discomfort.). |
禁忌 |
Diabetic ketoacidosis with or without coma. Renal disease or renal dysfunction (CrCL < 60 mL/min). Acute conditions with the potential to alter renal function eg, dehydration, severe infection, shock, intravascular administration of iodinated contrast agents. Acute or chronic disease which may cause tissue hypoxia eg, cardiac or respiratory failure, recent MI, shock. Hepatic impairment. Acute alcohol intoxication, alcoholism. Pregnancy, lactation. |
注意事項 |
Type 1 diabetes. Discontinue treatment when metabolic acidosis is suspected. Monitor creatinine concentration regularly. Avoid use in patients with hepatic impairment, including those with pre-treatment ALT or AST >3 x ULN. Liver enzyme monitoring should be performed prior to initiation of treatment. Caution use in CHF of NYHA functional class I-II. Avoid use in CHF of NYHA functional class III-IV. Monitor for skin disorders eg blistering or ulceration. teatment should be discontinued 48 hr before elective surgery with general anesth & should not usually be resumed earlier than 48 hr afterwards. Discontinued prior to, or at the time of, the radiological test using iodinated contrast agents & not reinstituted until 48 hrs afterwards, & only after renal function has been re-eva luated & found to be normal. |
不良反應 |
Tremor, dizziness, headache, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, metallic taste.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
交互作用 |
Diuretics (thiazides), corticosteroids, thyroid products, sympathomimetics, cationic drugs eg cimetidine, glucocorticoids, β2-agonists, ACE inhibitors. Alcohol, iodinated contrast media.
View more drug interactions with Galvus Met[高糖優美] |
本商品之市售規格 |
劑型 |
包裝 |
圖片 |
Galvus Met 50/500 mg 膜衣錠 |
|
Galvus Met 50/850 mg 膜衣錠 |
|
Galvus Met 50/1000 mg 膜衣錠 |
|
|
Manufacturer: |
Novartis |
Distributor: |
Novartis |
|
|
|
|